Related Experiment Videos
Leading structures of plant origin for drug development
1Institute of Pharmaceutical Biology, University of Munich, FRG.
Journal of Ethnopharmacology
|March 1, 1993
Summary
This review highlights 10 years of plant screening for novel compounds targeting inflammation, asthma, immunodeficiencies, and cardiovascular diseases. Key enzyme and immune system targets were investigated for potential therapeutic applications.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Immunology
Background:
- A decade-long plant screening program was conducted.
- The goal was to identify plant-derived compounds with therapeutic potential.
Purpose of the Study:
- To discover new plant constituents for treating inflammation, allergic asthma, immunodeficiencies, and cardiovascular diseases.
- To investigate structure-activity relationships of identified compounds.
Main Methods:
- Utilized in vitro assays focusing on prostaglandin metabolism enzymes.
- Employed in vitro assays for the unspecific immune system and ACE-inhibition.
- Used an in vivo plethysmographic system to model bronchial obstruction.
Main Results:
- Identified several plant constituents with significant pharmacological activity.
- Structure-activity relationship studies provided insights into compound efficacy.
- Demonstrated potential for treating inflammatory and cardiovascular conditions.
Conclusions:
- The plant screening program yielded valuable data on bioactive compounds.
- Results support the development of new plant-based therapeutics for target diseases.
- Further research into specific compounds is warranted.